Respiratory illness was categorised as: mild (fever or a cough, or both); moderate (fever, cough, tachypnoea and changes on chest x ray picture); and severe (with hypoxia or hypercapnia requiring ventilation). Diarrhoea was graded as mild (< 500 ml/day), moderate (500-1000 ml/day), or severe (> 1000 ml/day).
When GVHD was clinically diagnosed (skin rash or diarrhoea, or both, thought to be due to GVHD and requiring specific treatment) virological investigation was undertaken. Some such patients had GVHD alone, while in others viruses were isolated. Patients with GVHD in whom viruses were isolated were deemed to constitute a separate group.
Statistical analyses were performed by Fisher's exact probability test and the x2 test with Yates' correction.
Results

INCIDENCE AND TYPES OF VIRUS INFECTIONS
Thirty nine virus infections comprising 33 that were confirmed virologically and six VZV diagnosed clinically, were documented in 28 symptomatic bone marrow transplant recipients (tables 3 and 4). Fifty three patients had no detectable virus infections. Seven patients experienced more than one virus infection at different times during the study period (table 5) . One autologous recipient with a fever but no localising signs simultaneously had evidence of three virus infections (parainfluenza 3, coxsackie B3, and papovavirus). There was no association between the underlying reason for bone marrow transplantation and the viruses isolated.
The incidence of diagnosed virus infection was very similar in allogeneic and autologous recipients (15 in 32 patients and 18 in 49 patients, respectively). Virus infections in bone marrow transplant recipients The largest numbers of viruses causing symptoms were found in two main groups: herpes viruses-VZV (n = 9), CMV (n = 6), HSV (n = 6) and respiratory viruses-influenza A and B viruses (n = 5), parainfluenza viruses 2 and 3 (n = 3), and rhinoviruses (n = 2). Miscellaneous infections with adenoviruses (n = 4); papovavirus (n = 2); coxsackie virus B3 (n = 1) and astrovirus (n = 1) also occurred.
The serological state of the recipients with herpes viruses before transplantation was similar in allogeneic and autologous patients (table 6) . Over 80% of all recipients were seropositive to EBV, HSV, and VZV, and more than 50% had antibodies to CMV.
Overt CMV infection only occurred in six allogeneic recipients and was associated with a lower respiratory tract infection in three. There was no clear association between CMV infection and the serological state of the donor and recipient. In contrast to allogeneic recipients, CMV infection was not detected in autologous recipients (p = 0-006, Fisher's exact test).
Infections with HSV occurred occasionally, being documented in only six patients, and were not progressive. VZV infection occurred in nine patients, seven of whom were autograft recipients (p = 0-2, x2 test). Eight infections were manifest as localised zoster and one as chicken pox.
Paired sera were available for testing by complement fixation test in 15 patients. Diagnostic rises in complement fixation titres were recorded in four of 11 infections in allogeneic recipients and in none of the four infections in autologous recipients (data not shown).
Papovavirus was associated with fever in two patients. Paired sera were available only from Thirty five of the 81 bone marrow transplantation patients studied died, 18 due to recurrence of the underlying disease and three due to GVHD. Fourteen patients died of a variety of causes, including eight believed to have died due to an infectious agent. Permission for post mortem examination was given for seven patients, five of whom were allogeneic recipients. In the case of the remaining patient, who died of atypical pneumonia and bleeding, bronchoalveolar lavage and lung biopsy specimens were virologically examined six days before death and no virus was detected. Viruses were isolated from three of the seven patients (table 7) , although only one patient was considered to have died due to the virus infection (case 5).
VIRUS ISOLATIONS IN PATIENTS WITH GVHD BUT NO SYMPTOMS OF VIRAL INFECTION
Seven patients with GVHD and no overt 16 Despite a high prevalence of serum antibodies to VZV and HSV, the rate of detectable infections with these viruses was low: 6 21' and 7.40), respectively. In a multicentre study Watson reported a 400( incidence of zoster,'7 and Locksley and coworkers documented a rate of 16-60,. If our patients had been studied for longer the incidence of zoster might have been higher. The low incidence of HSV infection contrasts strongly with a rate of 800( for seropositive marrow recipients published by other workers. 19 The very low rate of HSV infection may reflect the prophylactic use of acyclovir. Furthermore, this may be a factor in the comparatively low rate of CMV infection found here. There is increasing evidence to support this hypothesis,' in particular a recent randomised placebo controlled trial showed that oral acyclovir significantly reduced CMV infection and disease in renal transplant recipients.20 Papovaviruses were detected by electron microscopical examination and therefore no differentiation between BK and JC viruses could be made. The allogeneic recipient found 
